NCT02533648View on ClinicalTrials.gov

Role of Allopurinol on Oxidative Stress and Mitochondrial Alterations in Skeletal Muscle of Diabetic Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

September 16, 2011

Primary Completion Date

February 29, 2016

Study Completion Date

February 18, 2016

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

2 capsules of allopurinol 150 mg daily for 3 month

2 capsules of allopurinol 150 mg daily for 3 month

DRUG

2 capsules of lactose daily for 3 month

2 capsules of lactose daily for 3 month

Trial Locations (1)

69310

CRNH Rhône Alpes, Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT02533648 - Role of Allopurinol on Oxidative Stress and Mitochondrial Alterations in Skeletal Muscle of Diabetic Patients | Biotech Hunter | Biotech Hunter